Table 2.

Dissolution-rate conformance and similarity of fluoroquinolone-based formulations containing 1.5% (w/v) XG-FT with the reference

Dosage form	TFLX				LVFX		CPFX
	Tablets	Crushed tablets	Uncoated fine granules	Film-coated fine granules	Tablets	Crushed tablets	Tablets	Crushed tablets
Conformance to specification	Yes	Yes	Yes	Yes	Yes	Yes	No	No
Judgement of similarity	No	No	No	Yes	Yes	No	No	No